Association of gastric acid and mucus secretion level with low-dose aspirin-induced gastropathy

Journal of Gastroenterology

Volumn 47, Issue 2, 2012, Pages 150-158

  Iijima, Katsunori ^a   Ara, Nobuyuki ^a   Abe, Yasuhiko ^a   Koike, Tomoyuki ^a   Iwai, Wataru ^a   Iwabuchi, Toshimitsu ^a   Ichikawa, Takafumi ^b   Kamata, Yayoi ^b   Ishihara, Kazuhiko ^b   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Aspirin; Gastric acid secretion; Gastric mucosal injury; H pylori

Indexed keywords

ACETYLSALICYLIC ACID; BAYASPIRIN; MUCIN; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTROSCOPY; HUMAN; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; STOMACH ACID; STOMACH ACID SECRETION; STOMACH DISEASE; STOMACH MUCOSA INJURY; STOMACH MUCUS; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; SECRETION; STOMACH MUCOSA;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; GASTRIC ACID; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; MUCINS; PROSPECTIVE STUDIES; STOMACH DISEASES;

EID: 84862336631     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0478-7     Document Type: Article

References (37)

1. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ. 1995;310:827-30.
2. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ. 2000;321:1183-7.
3. Allen A, Flemström G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol. 2005;288:C1-19 (review).
4. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev. 2008; 88(4):1547-65.
5. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008;135(1): 41-60. (Pubitemid 351899027)
6. Rowe PH, Starlinger MJ, Kasdon E, Hollands MJ, Silen W. Parenteral aspirin and sodium salicylate are equally injurious to the rat gastric mucosa. Gastroenterology. 1987;93:863-71. (Pubitemid 17156014)
7. Elliott SL, Ferris RJ, Giraud AS, Cook GA, Skeljo MV, Yeomans ND. Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH. Clin Exp Pharmacol Physiol. 1996;23: 432-4. (Pubitemid 26171549)
8. Iijima K, Ara N, Abe Y, Koike T, Iwai W, Uno K, et al. Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy. J Gastroenterol. 2011;46:612-9.
9. Sakai T, Ishihara K, Saigenji K, Hotta K. Recovery of mucin content in surface layer of rat gastric mucosa after HCl-aspirininduced mucosal damage. J Gastroenterol. 1997;32:157-63. (Pubitemid 27223076)
10. Azuumi Y, Ohara S, Ishihara K, Okabe H, Hotta K. Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut. 1980;21:533-6. (Pubitemid 10059416)
11. Marcinkiewicz M, Peura DA, Sarosiek J. The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration. Am J Gastroenterol. 1996;91: 360-5. (Pubitemid 26067349)
12. Jaworski T, Sarosiek I, Sostarich S, Roeser K, Connor M, Brotze S, et al. Restorative impact of rebeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance. Dig Dis Sci. 2005;50:357-65. (Pubitemid 40311548)
13. Ene MD, Clamp JR, Roberts CJC. Effects of cimetidine and carbenoxolone on gastric mucus. Gut. 1988;29:636-41.
14. Baron JH, Barr J, Batten J, Sidebotham R, Spencer J. Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol). Gut. 1986;27:486-90. (Pubitemid 16079747)
15. Wilson DE, Quadros E, Rajapaksa T, Adams A, Noar M. Effects of misoprostol on gastric mucus secretion in man. Dig Dis Sci. 1986;31(2 Supple):126S-30S.
16. Iijima K, Ohara S, Sekine H, Koike T, Kubota Y, Kato K, et al. New endoscopic method of gastric acid secretory testing. Am J Gasrtroenterol. 1998;93:2113-8. (Pubitemid 29076860)
17. Iijima K, Ichikawa T, Okada S, Ogawa M, Koike T, Ohara S, et al. Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test. Dig Dis Sci. 2009;54:1500-7.
18. Lanza FL, Graham DY, Davis RE, Rack MF. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxeninduced acute gastroduodenal injury. Effect of scoring method. Dig Dis Sci. 1990;35:1494-9.
19. Shimizu T, Akamatsu T, Sugiyama A, Ota H, Katsuyama T. Helicobacter pylori and the surface mucous gel layer of the human stomach. Helicobacter. 1996;1:207-18. (Pubitemid 126671163)
20. Iijima K, Ohara S, Koike T, Sekine H, Shimosegawa T. Gastric acid secretion of normal Japanese subjects in relation to Helicobacter pylori infection, aging, and gender. Scand J Gastroenterol. 2004;39:709-16. (Pubitemid 39093242)
21. Sarosiek J, Marcinkiewicz M, Parolisi S, Peura DA. Prostaglandin E2 content in residual gastric juice reflects endoscopic damage to the gastric mucosa after naproxen sodium administration. Am J Gastroenterol. 1996;91:873-8. (Pubitemid 26143522)
22. Konturek SJ, Brzozowski T, Stachura J, Dembinski A, Majka J. Role of gastric blood flow, neutrophil infiltration, and mucosal cell proliferation in gastric adaptation to aspirin in the rat. Gut. 1994;35:1189-96. (Pubitemid 24277329)
23. Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology. 1999;117:17-25. (Pubitemid 29297615)
24. Feldman M, Cryer B, Mallat D, Go MF. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. Am J Gastroenterol. 2001;96:1751-7.
25. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol. 2005;56(Suppl 5):33-55 (review).
26. Konturek PC, Brzozowski T, Pierzchalski P, Kwiecien S, Pajdo R, Hahn EG, et al. Activation of genes for spasmolytic peptide, transforming growth factor alpha and for cyclooxygenase (COX)-1 and COX-2 during gastric adaptation to aspirin damage in rats. Aliment Pharmacol Ther. 1998;12:767-77. (Pubitemid 28369884)
27. Romano M, Lesch CA, Meise KS, Veljaca M, Sanchez B, Kraus ER, et al. Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats. Gastroenterology. 1996;110:1448-55.
28. Kelly SM, Jenner JR, Dickinson RJ, Hunter JO. Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion. Gut. 1994;35:611-4. (Pubitemid 24163784)
29. Lipscomb GR, Painter J, Riley S, Gillott T, Rees W. Role of acid and salivary epidermal growth factor in gastric mucosal adaptation to naproxen in man. Scand J Gastroenterol. 1998;33:790-4. (Pubitemid 28423629)
30. Alderman BM, Ulaganathan M, Judd LM, Howlett M, Parker LM, Yeomans ND, et al. Insights into the mechanisms of gastric adaptation to aspirin-induced injury: a role for regenerating protein but not trefoil peptides. Lab Invest. 2003;83:1415-25. (Pubitemid 37267825)
31. Fiorucci S, de Lima OM Jr, Mencarelli A, Palazzetti B, Distrutti E, McKnight W, et al. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology. 2002;123:1598-606. (Pubitemid 35231659)
32. Fiorucci S, Distrutti E, de Lima OM, Romano M, Mencarelli A, Barbanti M, et al. Relative contribution of acetylated cyclooxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J. 2003;17:1171-3.
33. Davies NM, Sharkey KA, Asfaha S, Macnaughton WK, Wallace JL. Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther. 1997;11:1101-8.
34. Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci. 1983;28:1-6. (Pubitemid 13223395)
35. Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med. 1986;104:390-8 (review). (Pubitemid 16163622)
36. Lanas A, Rodrigo L, Márquez JL, Bajador E, Pérez-Roldan F, Cabrol J, et al. EMPHASYS Study Group Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole. Scand J Gastroenterol. 2003;38:693-700. (Pubitemid 36920489)
37. Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rensburg C, Rácz I, et al. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol. 2008;103:2465-73.